Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy‐proven diabetic nephropathy

Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findin...

Full description

Saved in:
Bibliographic Details
Published inDiabetic medicine Vol. 37; no. 12; pp. 2143 - 2152
Main Authors Morimoto, K., Matsui, M., Samejima, K., Kanki, T., Nishimoto, M., Tanabe, K., Murashima, M., Eriguchi, M., Akai, Y., Iwano, M., Shiiki, H., Yamada, H., Kanauchi, M., Dohi, K., Tsuruya, K., Saito, Y.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. Methods This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Results Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Conclusions Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. What’s new? In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not. Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy.
AbstractList Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. Methods This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Results Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Conclusions Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. What’s new? In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not. Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy.
Abstract Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. Methods This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Results Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions ( P  = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Conclusions Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy. What’s new? In diabetic nephropathy, the relationship between two histological vascular lesions in kidney tissues and future cardiovascular events is unclear. We evaluated hyalinosis in small arterioles of < 150 µm diameter, and intimal thickening in double‐layered large arteries of 150–300 µm diameter. Arteriolar hyalinosis was significantly associated with cardiovascular events, whereas intimal thickening in large arteries was not. Systolic blood pressure was strongly related to arteriolar hyalinosis but not to intimal thickening in large arteries, suggesting that hypertensive injury of smaller arterioles in the kidneys was more strongly associated with cardiovascular events and mortality than that of larger arteries in diabetic nephropathy.
AimsDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development.MethodsThis retrospective cohort study analysed 377 people with type 2 diabetes and biopsy‐proven diabetic nephropathy, with a median follow‐up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions.ResultsOf the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow‐up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan–Meier analysis than those without these lesions (P = 0.005, log‐rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model.ConclusionsArteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy.
Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly involve arteries larger than those affected in diabetic nephropathy. However, the association between diabetic nephropathy pathological findings and cardiovascular events has not been well studied. We aimed to investigate whether the pathological findings in diabetic nephropathy are closely associated with cardiovascular event development. This retrospective cohort study analysed 377 people with type 2 diabetes and biopsy-proven diabetic nephropathy, with a median follow-up of 5.9 years (interquartile range 2.0 to 13.5). We investigated how cardiovascular events were impacted by two vascular diabetic nephropathy lesions, namely arteriolar hyalinosis and arterial intimal thickening, and by glomerular and interstitial lesions. Of the 377 people with diabetic nephropathy, 331 (88%) and 295 (78%) had arteriolar hyalinosis and arterial intimal thickening, respectively. During the entire follow-up period, those with arteriolar hyalinosis had higher cardiovascular event rates in the crude Kaplan-Meier analysis than those without these lesions (P = 0.005, log-rank test). When fully adjusted for clinically relevant confounders, arteriolar hyalinosis independently predicted cardiovascular events [hazard ratio (HR) 1.99; 95% confidence interval (CI) 1.12, 3.86], but we did not find any relationship between arterial intimal thickening and cardiovascular events (HR 0.89; 95% CI 0.60, 1.37). Additionally, neither glomerular nor interstitial lesions were independently associated with cardiovascular events in the fully adjusted model. Arteriolar hyalinosis, but not intimal thickening of large arteries, was strongly associated with cardiovascular events in people with diabetic nephropathy.
Author Matsui, M.
Nishimoto, M.
Eriguchi, M.
Samejima, K.
Tsuruya, K.
Saito, Y.
Murashima, M.
Yamada, H.
Akai, Y.
Shiiki, H.
Dohi, K.
Iwano, M.
Morimoto, K.
Tanabe, K.
Kanki, T.
Kanauchi, M.
Author_xml – sequence: 1
  givenname: K.
  surname: Morimoto
  fullname: Morimoto, K.
  organization: Nara Medical University
– sequence: 2
  givenname: M.
  surname: Matsui
  fullname: Matsui, M.
  organization: Nara Medical University
– sequence: 3
  givenname: K.
  orcidid: 0000-0001-8273-5155
  surname: Samejima
  fullname: Samejima, K.
  email: ksame@naramed-u.ac.jp
  organization: Nara Medical University
– sequence: 4
  givenname: T.
  surname: Kanki
  fullname: Kanki, T.
  organization: Nara Medical University
– sequence: 5
  givenname: M.
  surname: Nishimoto
  fullname: Nishimoto, M.
  organization: Nara Medical University
– sequence: 6
  givenname: K.
  surname: Tanabe
  fullname: Tanabe, K.
  organization: Nara Medical University
– sequence: 7
  givenname: M.
  surname: Murashima
  fullname: Murashima, M.
  organization: Nara Medical University
– sequence: 8
  givenname: M.
  surname: Eriguchi
  fullname: Eriguchi, M.
  organization: Nara Medical University
– sequence: 9
  givenname: Y.
  surname: Akai
  fullname: Akai, Y.
  organization: Nara Medical University
– sequence: 10
  givenname: M.
  surname: Iwano
  fullname: Iwano, M.
  organization: Nara Medical University
– sequence: 11
  givenname: H.
  surname: Shiiki
  fullname: Shiiki, H.
  organization: Nara Medical University
– sequence: 12
  givenname: H.
  surname: Yamada
  fullname: Yamada, H.
  organization: Nara Medical University
– sequence: 13
  givenname: M.
  surname: Kanauchi
  fullname: Kanauchi, M.
  organization: Nara Medical University
– sequence: 14
  givenname: K.
  surname: Dohi
  fullname: Dohi, K.
  organization: Nara Medical University
– sequence: 15
  givenname: K.
  surname: Tsuruya
  fullname: Tsuruya, K.
  organization: Nara Medical University
– sequence: 16
  givenname: Y.
  surname: Saito
  fullname: Saito, Y.
  organization: Nara Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32276289$$D View this record in MEDLINE/PubMed
BookMark eNp10dFq1TAYB_AgE3c2vfAFJOCNgt2SJk3SS5lTBxNB9Lqk6dc1syepSbrROx_Bd_DNfBJz1jMvBuYmEH7fn_D9j9CB8w4Qek7JCc3ntNvCCeWM0EdoQ7ngRcVreoA2RPKyYETSQ3QU4zUhtKxZ_QQdsrKUolT1Bv3-Ak6PWIcEwfpRBzwserTORxvfYOcTti7ZbSZpsOY7OOuu8hPO8gr2Y5CljVjH6I3VCTp8a9OAjQ6d9Tc6mnmXCzfgUtzNTuCnEVbUWj_F5c_PX1PwGeDO6haSNdjBNAQ_6TQsT9HjXo8Rnu3vY_Tt_fnXs4_F5ecPF2dvLwvDBaWFbCklipCKkVoZ0QtZSaIFyIqrlkjJOtUC0X0FteyFULTkJSeVaVsp6p7X7Bi9WnPzX37MEFOztdHAOGoHfo5NyZRSVBAmMn35gF77OeRNZsUFIUxxyrJ6vSoTfIwB-mYKeZdhaShpds01ubnmrrlsX-wT53YL3T95X1UGpyu4tSMs_09q3n06XyP_AuQ1pyU
CitedBy_id crossref_primary_10_1038_s41440_023_01197_y
crossref_primary_10_1007_s40200_021_00765_8
crossref_primary_10_1111_dom_15347
crossref_primary_10_1136_bmjdrc_2020_001863
crossref_primary_10_1113_EP091520
crossref_primary_10_3390_molecules27248732
crossref_primary_10_34067_KID_0000000000000126
crossref_primary_10_1007_s10157_022_02221_0
crossref_primary_10_1186_s12902_022_00935_6
crossref_primary_10_1007_s10157_023_02433_y
Cites_doi 10.1253/circj.CJ-11-1033
10.1681/ASN.2007020220
10.2337/dc10-0555
10.1093/ndt/gft349
10.2215/CJN.04980515
10.1007/s10157-006-0453-4
10.1681/ASN.2010010010
10.1093/ndt/gfu250
10.1016/0046-8177(94)90039-6
10.1159/000443440
10.1111/j.2040-1124.2010.00074.x
10.2337/diab.24.1.1
10.1046/j.1523-1755.2002.00171.x
10.1373/clinchem.2008.103556
10.1681/ASN.2007010067
10.1136/bmj.317.7160.703
10.1159/000371727
10.1056/NEJMoa011303
10.2337/dc13-0298
10.1053/j.ajkd.2008.12.034
10.1097/00041552-199801000-00012
10.1007/s12013-015-0526-7
10.1046/j.1523-1755.2003.00712.x
ContentType Journal Article
Copyright 2020 Diabetes UK
2020 Diabetes UK.
Diabetic Medicine © 2020 Diabetes UK
Copyright_xml – notice: 2020 Diabetes UK
– notice: 2020 Diabetes UK.
– notice: Diabetic Medicine © 2020 Diabetes UK
DBID NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1111/dme.14301
DatabaseName PubMed
CrossRef
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Genetics Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef
Genetics Abstracts
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Nursing
EISSN 1464-5491
EndPage 2152
ExternalDocumentID 10_1111_dme_14301
32276289
DME14301
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministry of Health, Labour and Welfare of Japan
  funderid: 15K19462; 25293187
– fundername: Takeda Science Foundation
– fundername: Ministry of Health, Labour and Welfare of Japan
  grantid: 15K19462
– fundername: Ministry of Health, Labour and Welfare of Japan
  grantid: 25293187
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1OB
1OC
29F
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
ROL
RWI
RX1
SAMSI
SUPJJ
TEORI
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XV2
YFH
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c4611-7b11080053098c6f67570a6e7548b0773d8be0af5e97f6681242405cbb769f493
IEDL.DBID DR2
ISSN 0742-3071
IngestDate Fri Aug 16 04:28:24 EDT 2024
Thu Oct 10 20:38:40 EDT 2024
Fri Aug 23 00:54:58 EDT 2024
Sat Sep 28 08:34:03 EDT 2024
Sat Aug 24 01:04:18 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2020 Diabetes UK.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4611-7b11080053098c6f67570a6e7548b0773d8be0af5e97f6681242405cbb769f493
Notes These authors contributed equally to this study
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8273-5155
OpenAccessLink http://hdl.handle.net/10564/3780
PMID 32276289
PQID 2460038413
PQPubID 1006515
PageCount 10
ParticipantIDs proquest_miscellaneous_2388816036
proquest_journals_2460038413
crossref_primary_10_1111_dme_14301
pubmed_primary_32276289
wiley_primary_10_1111_dme_14301_DME14301
PublicationCentury 2000
PublicationDate December 2020
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: December 2020
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diabetic medicine
PublicationTitleAlternate Diabet Med
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 1994; 266
2007; 18
2010; 33
1988; 1
2010; 21
2013; 36
2010; 1
2009; 53
2002; 61
2015; 72
2015; 30
2015; 41
1998; 317
1975; 24
1994; 25
2016; 41
2008; 54
2014; 29
1998; 7
2007; 11
2003; 63
2012; 76
2001; 345
2016; 11
Hwa JJ (e_1_2_9_26_1) 1994; 266
Tracy RE (e_1_2_9_21_1) 1988; 1
e_1_2_9_11_1
e_1_2_9_10_1
e_1_2_9_13_1
e_1_2_9_12_1
e_1_2_9_15_1
e_1_2_9_14_1
e_1_2_9_17_1
e_1_2_9_16_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_20_1
e_1_2_9_22_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
References_xml – volume: 29
  start-page: 109
  year: 2014
  end-page: 118
  article-title: Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy
  publication-title: Nephrol Dial Transplant
– volume: 63
  start-page: 225
  year: 2003
  end-page: 232
  article-title: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)
  publication-title: Kidney Int
– volume: 1
  start-page: 212
  year: 2010
  end-page: 228
  article-title: Report of the committee on the classification and diagnostic criteria of diabetes mellitus
  publication-title: J Diabetes Investig
– volume: 41
  start-page: 66
  year: 2015
  end-page: 72
  article-title: Smoking‐related glomerulopathy: expanding the morphologic spectrum
  publication-title: Am J Nephrol
– volume: 7
  start-page: 71
  year: 1998
  end-page: 78
  article-title: Heterogeneity of endothelial function within the circulation
  publication-title: Curr Opin Nephrol Hypertens
– volume: 345
  start-page: 851
  year: 2001
  end-page: 860
  article-title: Renoprotective effect of the angiotensin‐receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
  publication-title: N Engl J Med
– volume: 1
  start-page: 420
  year: 1988
  end-page: 427
  article-title: Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program
  publication-title: Mod Pathol
– volume: 30
  start-page: 257
  year: 2015
  end-page: 266
  article-title: Renal histologic changes and the outcome in patients with diabetic nephropathy
  publication-title: Nephrol Dial Transplant
– volume: 18
  start-page: 2135
  year: 2007
  end-page: 2142
  article-title: Prehypertension increases the risk for renal arteriosclerosis in autopsies: the Hisayama Study
  publication-title: J Am Soc Nephrol
– volume: 53
  start-page: 982
  year: 2009
  end-page: 992
  article-title: Revised equations for estimated GFR from serum creatinine in Japan
  publication-title: Am J Kidney Dis
– volume: 25
  start-page: 1213
  year: 1994
  end-page: 1227
  article-title: Insudative lesions—their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypothesis based on single views of advancing human diabetic nephropathy
  publication-title: Hum Pathol
– volume: 76
  start-page: 1526
  year: 2012
  end-page: 1532
  article-title: Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial
  publication-title: Circ J
– volume: 61
  start-page: 648
  year: 2002
  end-page: 654
  article-title: Cigarette smoking and vascular pathology in renal biopsies
  publication-title: Kidney Int
– volume: 72
  start-page: 751
  year: 2015
  end-page: 756
  article-title: The endothelium as a target for the treatment of heart failure
  publication-title: Cell Biochem Biophys
– volume: 18
  start-page: 2644
  year: 2007
  end-page: 2648
  article-title: End‐stage renal disease in the United States: an update from the United States Renal Data System
  publication-title: J Am Soc Nephrol
– volume: 33
  start-page: 1395
  year: 2010
  end-page: 1402
  article-title: Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
  publication-title: Diabetes Care
– volume: 266
  start-page: H952
  year: 1994
  end-page: H958
  article-title: Comparison of acetylcholine‐dependent relaxation in large and small arteries of rat mesenteric vascular bed
  publication-title: Am J Physiol
– volume: 36
  start-page: 3655
  year: 2013
  end-page: 3662
  article-title: Long‐term outcomes of Japanese type 2 diabetic patients with biopsy‐proven diabetic nephropathy
  publication-title: Diabetes Care
– volume: 54
  start-page: 1379
  year: 2008
  end-page: 1385
  article-title: Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden
  publication-title: Clin Chem
– volume: 11
  start-page: 41
  year: 2007
  end-page: 50
  article-title: Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease
  publication-title: Clin Exp Nephrol
– volume: 41
  start-page: 374
  year: 2016
  end-page: 383
  article-title: Relationship between type of hypertension and renal arteriolosclerosis in chronic glomerular disease
  publication-title: Kidney Blood Press Res
– volume: 21
  start-page: 556
  year: 2010
  end-page: 563
  article-title: Renal Pathology Society. Pathologic classification of diabetic nephropathy
  publication-title: J Am Soc Nephrol
– volume: 24
  start-page: 1
  year: 1975
  end-page: 9
  article-title: Onset and progression of diabetic glomerulosclerosis; a prospective study based on serial renal biopsies
  publication-title: Diabetes
– volume: 317
  start-page: 703
  year: 1998
  end-page: 713
  article-title: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group
  publication-title: BMJ
– volume: 11
  start-page: 593
  year: 2016
  end-page: 601
  article-title: Prognostic value of tubulointerstitial lesions, urinary ‐acetyl‐β‐ ‐glucosaminidase, and urinary β2‐microglobulin in patients with type 2 diabetes and biopsy‐proven diabetic nephropathy
  publication-title: Clin J Am Soc Nephrol
– ident: e_1_2_9_17_1
  doi: 10.1253/circj.CJ-11-1033
– ident: e_1_2_9_2_1
  doi: 10.1681/ASN.2007020220
– ident: e_1_2_9_15_1
  doi: 10.2337/dc10-0555
– ident: e_1_2_9_7_1
  doi: 10.1093/ndt/gft349
– ident: e_1_2_9_9_1
  doi: 10.2215/CJN.04980515
– ident: e_1_2_9_11_1
  doi: 10.1007/s10157-006-0453-4
– ident: e_1_2_9_5_1
  doi: 10.1681/ASN.2010010010
– ident: e_1_2_9_8_1
  doi: 10.1093/ndt/gfu250
– ident: e_1_2_9_18_1
  doi: 10.1016/0046-8177(94)90039-6
– ident: e_1_2_9_19_1
  doi: 10.1159/000443440
– ident: e_1_2_9_12_1
  doi: 10.1111/j.2040-1124.2010.00074.x
– ident: e_1_2_9_27_1
  doi: 10.2337/diab.24.1.1
– ident: e_1_2_9_22_1
  doi: 10.1046/j.1523-1755.2002.00171.x
– ident: e_1_2_9_13_1
  doi: 10.1373/clinchem.2008.103556
– ident: e_1_2_9_14_1
  doi: 10.1681/ASN.2007010067
– ident: e_1_2_9_20_1
  doi: 10.1681/ASN.2007010067
– volume: 1
  start-page: 420
  year: 1988
  ident: e_1_2_9_21_1
  article-title: Blood pressure, nephrosclerosis, and age autopsy findings from the Honolulu Heart Program
  publication-title: Mod Pathol
  contributor:
    fullname: Tracy RE
– ident: e_1_2_9_16_1
  doi: 10.1136/bmj.317.7160.703
– ident: e_1_2_9_23_1
  doi: 10.1159/000371727
– volume: 266
  start-page: H952
  year: 1994
  ident: e_1_2_9_26_1
  article-title: Comparison of acetylcholine‐dependent relaxation in large and small arteries of rat mesenteric vascular bed
  publication-title: Am J Physiol
  contributor:
    fullname: Hwa JJ
– ident: e_1_2_9_3_1
  doi: 10.1056/NEJMoa011303
– ident: e_1_2_9_6_1
  doi: 10.2337/dc13-0298
– ident: e_1_2_9_10_1
  doi: 10.1053/j.ajkd.2008.12.034
– ident: e_1_2_9_25_1
  doi: 10.1097/00041552-199801000-00012
– ident: e_1_2_9_24_1
  doi: 10.1007/s12013-015-0526-7
– ident: e_1_2_9_4_1
  doi: 10.1046/j.1523-1755.2003.00712.x
SSID ssj0012939
Score 2.440077
Snippet Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly...
Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly...
Abstract Aims Diabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which...
AimsDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly...
AIMSDiabetic nephropathy, a pathologically diagnosed microvascular complication of diabetes, is a strong risk factor for cardiovascular events, which mainly...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 2143
SubjectTerms Biopsy
Cardiovascular diseases
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetic nephropathy
Diuretics
Lesions
Microvasculature
Nephropathy
Risk factors
Veins & arteries
Title Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy‐proven diabetic nephropathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.14301
https://www.ncbi.nlm.nih.gov/pubmed/32276289
https://www.proquest.com/docview/2460038413
https://search.proquest.com/docview/2388816036
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB1VlUBseJRXSkEGsWBBqjycOBErBK0qpMuiolIXSJHtjEVUmlyRexe3Kz6Bf-DP-BJmnIe4ICTELkrGSmJ7Zs6Mx8cAz12EzprYhbW2MpQpkh0ssQ6lLQi9mriOM97gvHifn5zJd-fZ-Q68mvbCDPwQc8KNNcPba1ZwbfpflLy-RFLz1O_dYiI9BkSnM3UUu7FyoOBMOL8Sj6xCXMUzt9z2RX8AzG286h3O8S34OH3qUGdycbhemUN79RuL43_-y224OQJR8XqYOXdgB9s9uL4Yl9r34NqYR7gL30-RJX3xZ8ORsPi0IfTedn3TvxRttxJNu2ouSYRr5y-QMy10S3zmIvOxGZJk0ws9TgasBSeAhd2qhhWeTarntkNh-yBkmm7Zb358_cbpD2zFkC5urGhxyYc8EIbd3IOz46MPb07C8WyH0Mo8jkNleP8Bm4CoLGzuKG5Rkc5RUQRlIqXSujAYaZdhqVzOJGmSsEdmjVF56WSZ3ofdtmvxIYjMFNppabVWRrqEIjBEpZWmSDSJnU4CeDaNcrUcKDyqKfShjq98xwdwMI1_NWpxXyUy55VT8vMBPJ0fk_7xoopusVuTTFoUBZ_VnQfwYJg381vIWJKvKcoAXvjR__vrq7eLI3-x_--ij-BGwsG_r605gN3VlzU-JoS0Mk-8KvwEFegPcQ
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtUwEB1VRTw2PMqjgQIGsWBBqjycOJHYINrqAr1dVK3UDYpsxxZR2-SK5C4uKz6Bf-DP-BJmnIe4ICTELkrGSmL7zON4PAZ4YQNjtQqtX0rNfR4b1IO5KX2uM_ReVViGCW1wnh-ls1P-_iw524DX416Yvj7ERLgRMpy-JoATIf0LystLgziPafPWFYR7QrDcO56KR5Ehy_sinBExLOFQV4jyeKam69boDxdz3WN1JufgFnwcP7bPNDnfXXZqV3_5rY7j__7Nbbg5-KLsTT957sCGqbfg2nxYbd-CqwOVcBe-HxuSdPmfFQXD7NMKHfi6aav2FaubjlV1V12iCKXPnxsiW_AWu6A886GZQcmqZXKYD6ZkxAEzvZYQy1xBqZba9rntvZCqmkW7-vH1GzEgpmY9Y1xpVpsFnfOAbuzqHpwe7J-8nfnD8Q6-5mkY-kLRFgTSAkGe6dTiEIpApkZgEKUCIeIyUyaQNjG5sCnVSePofiRaKZHmlufxfdism9psA0tUJq3kWkqhuI0wCDNGSCExGI1CKyMPno_DXCz6Kh7FGP1gxxeu4z3YGSdAMQC5LSKe0uIpmnoPnk2PEYK0riJr0yxRJs6yjI7rTj140E-c6S2oL9HcZLkHL93w__31xd583108_HfRp3B9djI_LA7fHX14BDci4gJcqs0ObHafl-YxOkydeuJw8RMBfROR
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRVRceBQogQIGceBAqjwcOxEnxHZVHluhiko9IEW2Y4uoNFmR7GE58RP4D_wzfgkzeYkFISFuUTJWEtsz88348xjgiQusMzp0fqEM93ls0Q5mtvC5SRG96rAIE9rgvDgWR6f89VlytgXPx70wfX2IKeFGmtHZa1LwZeF-UfLiwqKax7R36xIXcUSR1-xkqh1Ffizra3BGlGAJh7JCROOZmm46oz8Q5iZg7TzO_Bp8GL-1J5qcH6xafWC-_FbG8T9_5jpcHZAoe9FPnRuwZatd2FkMa-27cHlIJNyE7yeWJDv2Z0mhMPu4Rvhe1U3ZPGNV3bKyassLFCHy_LmlVAveYp-IZT40syhZNkwNs8EWjDLAzGzQYVlXTqqhtj2zvRfSZb1s1j--fqP8h61Yny8uDavskk55QBC7vgWn88P3L4_84XAH33ARhr7UtAGBbECQpUY4DFxkoISVGELpQMq4SLUNlEtsJp2gKmkcwUditJYiczyLb8N2VVf2DrBEp8opbpSSmrsIQzBrpZIKQ9EodCry4PE4yvmyr-GRj7EPdnzedbwH--P454MaN3nEBS2doqP34NH0GBWQVlVUZesVysRpmtJh3cKDvX7eTG9Ba4nOJs08eNqN_t9fn88Wh93F3X8XfQg772bz_O2r4zf34EpEiYCOZ7MP2-3nlb2PaKnVDzqt-AnDdRJA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Renal+arteriolar+hyalinosis%2C+not+intimal+thickening+in+large+arteries%2C+is+associated+with+cardiovascular+events+in+people+with+biopsy-proven+diabetic+nephropathy&rft.jtitle=Diabetic+medicine&rft.au=Morimoto%2C+K&rft.au=Matsui%2C+M&rft.au=Samejima%2C+K&rft.au=Kanki%2C+T&rft.date=2020-12-01&rft.eissn=1464-5491&rft.volume=37&rft.issue=12&rft.spage=2143&rft_id=info:doi/10.1111%2Fdme.14301&rft_id=info%3Apmid%2F32276289&rft.externalDocID=32276289
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon